The Cancer Control and Outcomes Program is one of three scientific programs in the ECOG-ACRIN Cancer Research Group. This program addresses a broad range of research aims, primarily those that are part of the cancer control continuum, which is widely recognized throughout the research community as including: cancer prevention, early detection, diagnosis and surveillance, treatment, and survivorship.
![]() |
Lynne I. Wagner, PhD
Wake Forest University and the Comprehensive Cancer Center of Wake Forest University
|
![]() |
Mitchell D. Schnall, MD, PhD
University of Pennsylvania
|
![]() |
Peter J. O’Dwyer, MD
University of Pennsylvania and the Abramson Cancer Center
Email
|
![]() |
Chair
Michael A. Thompson, MD, PhD
Aurora NCORP
|
![]() |
Co-Chair
Al B. Benson III, MD, FACP, FASCO
Northwestern University and the Robert H. Lurie Comprehensive Cancer Center
|
![]() |
Co-Chair
Mary Lou Smith, JD, MBA
Research Advocacy Network
|
ECOG-ACRIN’s Cancer Control and Outcomes program aims to significantly reduce the burden of cancer on individual and societal levels by designing and conducting practice-changing clinical trials that span the entire continuum, from prevention through survivorship, in the communities where individuals receive their care. This program also engages in health equity research by studying determinants of disparities in cancer clinical trials, promoting accrual, and addressing the unique needs of younger and older adults diagnosed with cancer. Across the program, there is an emphasis on cancer care delivery research. For more information about the cancer control continuum, visit the NCI website.
There are four large scientific committees within the Cancer Control and Outcomes Program. Each committee has its own scientific aims. Some have subcommittees working groups.
To learn more, visit the NCORP Research Base section.
![]() | Scientific Programs |
![]() | Cancer Control and Outcomes Program |
![]() | Therapeutic Studies Program |
![]() | Biomarker Sciences Program |
© 2012-2020 ECOG-ACRIN Cancer Research Group. All rights reserved. | Disclaimer